Lectus Therapeutics is a drug discovery and development company.
Lectus Therapeutics Limited is a UK-based pharmaceutical company. Its mission is to build a development pipeline containing first-in-class ion channel therapeutics identified through the use of its proprietary proteomics technology for pain management and the treatment of urinary bladder disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 3, 2003 | Seed | — | 1 | Sulis Innovation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sulis Innovation | Yes | Seed |